Results 21 to 30 of about 3,138,389 (246)
Be(a)ware of Leukocytosis in Papillary Thyroid Cancer
Case Reports in Endocrinology, 2022 Leukocytosis can be present at any time during various malignancies. A 42-year-old male was admitted to our department for surgical management of his metastatic papillary thyroid cancer. Persistent white blood cell (WBC) elevation with left shift led to a thorough investigation.
Styliani Laskou +4 more
openaire +3 more sources
Frontiers in Endocrinology, 2023 BackgroundExtrathyroidal extension is a major risk factor for poor prognosis in papillary thyroid cancer. However, the effect of different degrees of extrathyroidal extension on prognosis remains controversial.
Ming Xu +7 more
doaj +1 more source
miR-191 downregulation plays a role in thyroid follicular tumors through CDK6 targeting [PDF]
, 2010 miR-191 expression is frequently altered in several neoplasias, being upregulated in some, such as pancreatic, colon, lung and prostate carinomas, and downregulated in others, such as severe medulloblastomas and melanomas.
Colamaio, Marianna
core +1 more source
Metastatic Neck Disease in Multifocal Thyroid Papillary Cancer
Haseki Tıp Bülteni, 2018 Aim:Multifocal papillary thyroid cancer (MPTC) has aggressive and poor prognosis. The main aim of this study was to evaluate the lymph node metastasis pattern in MPTC patients.Methods:We retrospectively investigated the records of 2530 patients who ...
Burak Ertaş +5 more
doaj +1 more source
Medical Sciences, 2019 The re-naming of noninvasive follicular variant papillary thyroid cancer to the apparently non-malignant, noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) impacts the prevalence of malignancy rates, thereby affecting ...
Rupendra T. Shrestha +2 more
doaj +1 more source
“The potential role of CXCR4 and SDF-1 as indicators of tumor aggressiviness in patients with conventional papillary thyroid carcinoma” [PDF]
, 2008 Background: Functional chemokine receptors are expressed in many malignant tumors, including papillary thyroid carcinoma (PTC). These receptors promote tumor growth and metastasis in response to endogenous chemokines.
Pagano, Loredana
core +1 more source
Papillary Thyroid Carcinoma: Current Position in Epidemiology, Genomics, and Classification
, 2022 Papillary thyroid carcinoma is the most common type of thyroid malignancy both in adults and pediatric population. Since the 1980s, there are changes in criteria in labelling thyroid lesions as “papillary thyroid carcinomas.” Radiation exposure is a well-
Lam, AK
core +1 more source
A Recurrent Episode of Dermatomyositis Associated with Papillary Thyroid Cancer
Case Reports in Endocrinology, 2017 Objective. It is uncommon for dermatomyositis to be associated with papillary thyroid cancer. We report an unusual case of papillary thyroid cancer presenting with dermatomyositis. Methods.
Vijay Gopal Eranki
doaj +1 more source
Relationship between serum NDRG3 and papillary thyroid carcinoma
Frontiers in Endocrinology, 2022 BackgroundIn recent years, papillary thyroid carcinoma is considered to be one of the fastest increaseing cancer. NDRG family member 3 (NDRG3) has been proposed as a molecular marker of tumor, and is expected to be used in clinic.MethodsEnzyme-linked ...
Jiahao Wang +5 more
doaj +1 more source
Loss of Rap1GAP in Papillary Thyroid Cancer [PDF]
Molecular Endocrinology, 2009 Rap1 GTPase-activating protein (GAP) regulates the activity of Rap1, a putative oncogene. We previously reported Rap1GAP was highly expressed in normal human thyroid cells and decreased in five papillary thyroid carcinomas (PTCs).To confirm the significance of these findings, we analyzed Rap1GAP expression in a larger set of benign tumors (adenomas and
Anoma, Nellore +12 more
openaire +3 more sources